CA1302250C - Methode pour le diagnostic de la maladie d'alzheimer - Google Patents

Methode pour le diagnostic de la maladie d'alzheimer

Info

Publication number
CA1302250C
CA1302250C CA000533788A CA533788A CA1302250C CA 1302250 C CA1302250 C CA 1302250C CA 000533788 A CA000533788 A CA 000533788A CA 533788 A CA533788 A CA 533788A CA 1302250 C CA1302250 C CA 1302250C
Authority
CA
Canada
Prior art keywords
phf
tau protein
disease
csf
phfa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000533788A
Other languages
English (en)
Inventor
Khalid Iqbal
Henryk M. Wisniewski
Inge Grundke-Iqbal
Pankaj D. Mehta
Richard J. Kascsak
Gian Ping Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation for Mental Hygiene Inc
Original Assignee
Research Foundation for Mental Hygiene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation for Mental Hygiene Inc filed Critical Research Foundation for Mental Hygiene Inc
Application granted granted Critical
Publication of CA1302250C publication Critical patent/CA1302250C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA000533788A 1986-04-04 1987-04-03 Methode pour le diagnostic de la maladie d'alzheimer Expired - Fee Related CA1302250C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84841086A 1986-04-04 1986-04-04
US848,410 1986-04-04
US87660586A 1986-06-20 1986-06-20
US876,605 1992-04-30

Publications (1)

Publication Number Publication Date
CA1302250C true CA1302250C (fr) 1992-06-02

Family

ID=27126774

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000533788A Expired - Fee Related CA1302250C (fr) 1986-04-04 1987-04-03 Methode pour le diagnostic de la maladie d'alzheimer

Country Status (1)

Country Link
CA (1) CA1302250C (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU711140B2 (en) * 1994-12-23 1999-10-07 Albert Einstein College Of Medicine Of Yeshiva University Antigen, antibodies and diagnostic assay for Alzheimer's disease
WO2002075318A3 (fr) * 2001-03-20 2004-03-11 Univ Aberdeen Marqueurs neurofibrillaires

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU711140B2 (en) * 1994-12-23 1999-10-07 Albert Einstein College Of Medicine Of Yeshiva University Antigen, antibodies and diagnostic assay for Alzheimer's disease
WO2002075318A3 (fr) * 2001-03-20 2004-03-11 Univ Aberdeen Marqueurs neurofibrillaires

Similar Documents

Publication Publication Date Title
JP3544544B2 (ja) 診断マーカーとしてのヒト好中球リポカリン（ｈｎｌ）の使用および抗−ｈｎｌ−抗体調製物
US7674599B2 (en) Methods of using antibodies to detect alpha-synuclein in fluid samples
CA2480466C (fr) Detection et/ou surveillance de maladies liees a la synucleine
US6762032B1 (en) Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
EP0891553B1 (fr) Methode de detection des encephalopathies spongiformes transmissibles
US20070184504A1 (en) Assay for anti-INGAP antibodies
US20040023309A1 (en) Immunoassay and kit for an early and simultaneous detection of biochemical markers in a patient's sample
JPH02503714A (ja) ＩｇＡ腎臓病の診断のための方法及びキツト
AU2007283186A1 (en) Improved immunoassay involving mutant antigens to reduce unspecific binding
JP2000515854A (ja) 脳タンパク質ｓ―１００の存在の測定方法
KR20090009579A (ko) 알츠하이머병 진단용 마커 및 이를 이용한 진단키트
CA1302250C (fr) Methode pour le diagnostic de la maladie d'alzheimer
EP0909278A1 (fr) Immunoglobuline g liee a la nephropathie et anticorps contre celle-ci
EP1371986A1 (fr) Diagnostic de la maladie d'Alzheimer basé sur le rapport entre hAbèta42 et hAbèta40
WO2001011368A1 (fr) Technique et reactif utilises pour l'analyse de la melanotransferrine associee a l'arthrite
JP2915530B2 (ja) ラミニン フラグメント
JP2878317B2 (ja) ラミニン測定試薬
JP3225248B2 (ja) 検出方法
KR920010224B1 (ko) 응집반응 측정법
JP4363767B2 (ja) 多発性硬化症の検査方法
JP3542240B2 (ja) 透析アミロイドーシス用マーカーとしての使用および透析アミロイドーシス用免疫試薬
AU2002346529B2 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
Hara et al. Enzyme immunoassay for measuring antibodies against skeletal muscle in patients with myasthenia gravis
JPH06194367A (ja) リウマチ疾患の診断方法
KR20200077779A (ko) 퇴행성 뇌질환 발병 위험성 예측용 조성물 및 이를 이용한 퇴행성 뇌질환의 발병 위험성 예측 방법

Legal Events

Date Code Title Description
MKLA Lapsed